Abcb1 Mdr1
Abcb1 Mdr1 - Related Videos
12:25
Epigenome-Wide CRISPR-Cas9-Based Knockout Screens on Chemoresistant Cells
0 Views •
2026
Here, we present a protocol for generating chemoresistant cells using a dose-escalation approach, followed by a CRISPR/Cas9-based screen using a focused sgRNA library targeting epigenetic modifiers to identify regulators of acquired chemoresistance. The protocol also provides multiple optimization points tailored to chemoresistant cell models, offering a robust framework for researchers investigating resistance mechanisms.
FAQs
ABCB1 Mdr1 links ATP hydrolysis to substrate export across the plasma membrane. The transporter binds compounds inside the cell or within the membrane and uses energy released from ATP breakdown to drive their movement outward. This coupling lowers intracellular exposure to transported substances and enables one protein to handle chemically diverse compounds.
P-glycoprotein has the functional capacity to bind and export a broad range of structurally diverse compounds rather than a single chemical class. This wide substrate profile explains why its activity can influence the cellular levels of numerous therapeutic drugs and why transporter-mediated export is important when evaluating compound distribution and persistence.
ABCB1 is the gene name used for the transporter system described in the overview, whereas Mdr1 is the corresponding designation in rodents. Recognizing this naming relationship helps researchers interpret findings across species without treating the terms as unrelated proteins. The encoded product is P-glycoprotein, the ATP-dependent membrane transporter responsible for export activity.
Transporter activity at protective barriers can limit how much of a compound enters or remains within particular tissues. Expression in the intestine, liver, kidney, and blood-brain barrier therefore connects ABCB1 Mdr1 with drug absorption, distribution, and elimination. Its effects are especially relevant when estimating intracellular or tissue exposure to therapeutic drugs.
ABCB1 Mdr1 is important because transporter-mediated export can change the intracellular accumulation of many compounds, including therapeutic drugs. In pharmacology, this relationship helps frame how drug exposure may be controlled across tissues. In toxicology, the same protective activity is relevant to how cells restrict accumulation of potentially harmful substances.
P-glycoprotein contributes to the study of multidrug resistance because its broad export capability can reduce intracellular accumulation of multiple therapeutic drugs. This makes ABCB1 Mdr1 relevant to cancer research as well as to other biological systems in which transporter activity may affect how cells respond to compounds and how drug exposure is maintained.